HR and inflammatory breast carcinoma: Furthermore, IBC can be characterized according to phenotypic expression of estrogen/progesterone hormone receptors (HR) and HER2 and often is grouped into 4 distinct biologic subtypes (HR+/HER2−, HR+/HER2+, HR−/HER2+, HR−/HER2−) [24].